677 results match your criteria Cavernous Liver Hemangioma Imaging


Hepatic Sclerosing Hemangioma Simulating Gallbladder Carcinoma: A Rare Case.

J Clin Exp Hepatol 2018 Dec 19;8(4):474-477. Epub 2018 Jul 19.

Icahn School of Medicine at Mount Sinai, Department of Pathology New York, NY, USA 10029-6574.

Sclerosing hemangiomas of the liver are rare benign tumors of the liver. Although hepatic hemangiomas are the most common benign liver tumor, they are mostly cavernous in nature. A hepatic sclerosing hemangioma is defined by presence of fibrosis and hyalinization as a result of degenerative changes in a cavernous hemangioma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jceh.2018.07.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286440PMC
December 2018
2 Reads

Hepatic Sclerosing Hemangioma with Predominance of the Sclerosed Area Mimicking a Biliary Cystadenocarcinoma.

Case Reports Hepatol 2018 4;2018:7353170. Epub 2018 Oct 4.

Department of Diagnostic Pathology, Juntendo University Nerima Hospital, Japan.

We report here an extremely rare case of hepatic sclerosing hemangioma mimicking a biliary cystadenocarcinoma. A previously healthy 39-year-old woman was referred to our hospital because of a large tumor in the liver. Abdominal computed tomography revealed early peripheral ring enhancement in the arterial phase and slight internal heterogeneous enhancement in the delayed phase. Read More

View Article

Download full-text PDF

Source
https://www.hindawi.com/journals/crihep/2018/7353170/
Publisher Site
http://dx.doi.org/10.1155/2018/7353170DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193354PMC
October 2018
4 Reads

Preoperative diagnosis of the sclerosed hemangioma of the liver using multimodality imaging findings: A case report.

Radiol Case Rep 2018 Oct 1;13(5):1025-1029. Epub 2018 Jun 1.

Department of Pathology, Fukui Prefectural Hospital, 2-8-1 Yotsui, Fukui 910-8526, Japan.

A sclerosed hemangioma of the liver is a rare benign lesion characterized by fibrosis and hyalinization of a hepatic cavernous hemangioma as a result of degeneration. This condition has been difficult to correctly diagnose with imaging. Our patient was a 57-year-old man whose computed tomography (CT) scan showed a mass of 45 mm in diameter in the lateral segment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radcr.2018.04.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137339PMC
October 2018
4 Reads

Utility of contrast-enhanced ultrasonography with perflubutane in evaluating indications for diagnostic percutaneous tumor biopsy in a case of hepatic sclerosed hemangioma.

Clin J Gastroenterol 2018 Dec 21;11(6):514-520. Epub 2018 Jun 21.

Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan.

Sclerosed hemangioma is difficult to distinguish from intrahepatic cholangiocarcinoma or liver metastasis due to their imaging resemblance, thus pathological diagnosis is often required; however, percutaneous biopsy entails a risk of dissemination if the tumor is malignant. Perflubutane, a contrast agent of ultrasonography, has a characteristic feature of being phagocytosed by Kupffer cells. Hepatic malignant lesions contain few or no Kupffer cells, therefore, they are shown as a contrast defect. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12328-018-0880-2DOI Listing
December 2018
3 Reads

Multiple hepatic sclerosing hemangiomas: a case report and review of the literature.

Surg Case Rep 2018 Jun 19;4(1):60. Epub 2018 Jun 19.

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka, 812-8582, Japan.

Background: Hepatic sclerosing hemangioma, a very rare benign tumor, is characterized by fibrosis and hyalinization occurring in association with degeneration of a hepatic cavernous hemangioma. Such atypical hemangiomas can be diagnosed incorrectly as primary or metastatic malignancies based on imaging characteristics. We present herein a rare case of giant and multiple hepatic sclerosing hemangiomas that are difficult to differentiate from hepatic malignancies and review the relevant literature. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40792-018-0468-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006004PMC
June 2018
25 Reads

[Differential diagnosis of hepatocellular carcinoma and hepatic hemangiomas based on radiomic features of gadoxetate disodium-enhanced magnetic resonance imaging].

Nan Fang Yi Ke Da Xue Xue Bao 2018 Apr;38(4):428-433

School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China. E-mail:

Objective: To evaluate the feasibility of using radiomic features for differential diagnosis of hepatocellular carcinoma (HCC) and hepatic cavernous hemangioma (HHE).

Methods: Gadoxetate disodium-enhanced magnetic resonance imaging data were collected from a total of 135 HCC and HHE lesions. The radiomic texture features of each lesion were extracted on the hepatobiliary phase images, and the performance of each feature was assessed in differentiation and classification of HCC and HHE. Read More

View Article

Download full-text PDF

Source
April 2018
6 Reads

Atypical hemangioma mimicking mixed hepatocellular cholangiocarcinoma: Case report.

Medicine (Baltimore) 2017 Dec;96(50):e9192

State Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University.

Rationale: Hemangioma of the liver is a benign hepatic tumor, more common in women than in men, which is typically asymptomatic, solitary, and incidentally discovered. Atypical hemangioma is a variant of hepatic hemangioma with atypical imaging finding features on CT and MRI that can be confused with hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and mixed hepatocellular cholangiocarcinoma (HCC-CC).

Patient Concerns: We report a case of atypical hepatic hemangioma mimicking HCC-CC: A 59-year-old man was referred to our hospital for a hepatic lesion that was 4. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000009192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815745PMC
December 2017
6 Reads

Hepatic cavernous hemangiomas: long-term (> 5 years) follow-up changes on contrast-enhanced dynamic computed tomography or magnetic resonance imaging and determinant factors of the size change.

Radiol Med 2018 May 22;123(5):323-330. Epub 2018 Jan 22.

Department of Radiology, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul, 06273, South Korea.

Purpose: To investigate the very long-term (> 5 years) follow-up changes of hepatic cavernous hemangiomas and to evaluate possible determinant factors for the changes.

Materials And Methods: Among 1115 consecutive patients suspected of having hepatic hemangiomas based on imaging features, 101 patients with comparable computed tomography or magnetic resonance imaging data during a 5-year follow-up interval in the Picture Archiving and Communication System were analyzed. Two radiologists independently determined the largest dimension of each lesion on axial images. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11547-018-0854-y
Publisher Site
http://dx.doi.org/10.1007/s11547-018-0854-yDOI Listing
May 2018
22 Reads

Hepatic sclerosed hemangioma with special attention to diffusion-weighted magnetic resonance imaging.

Surg Case Rep 2018 Jan 3;4(1). Epub 2018 Jan 3.

Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-0811, Japan.

Background: A hepatic sclerosed hemangioma (HSH) is a very rare benign liver tumor. The correct preoperative diagnosis of HSH is very difficult because its features of imaging are similar to those of intrahepatic cholangiocarcinoma or colorectal liver metastasis.

Case Presentation: We experienced five patients who were diagnosed histologically with HSH. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40792-017-0414-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752647PMC
January 2018
13 Reads

Hepatic Angiosarcoma Masquerading as Hemangioma: A Challenging Differential Diagnosis.

Acta Med Port 2017 Oct 31;30(10):750-753. Epub 2017 Oct 31.

Serviço de Cirurgia A. Centro Hospitalar e Universitário de Coimbra. Coimbra. Portugal; Departamento de Cirurgia. Faculdade de Medicina. Universidade de Coimbra. Coimbra. Portugal.

Hemangiomas are usually diagnosed based on ultrasound findings. The presence of symptoms, rapid growth or atipical imagiological findings should make us consider other diagnoses, including malignant tumors such as angiosarcomas. We describe the case of a previously healthy 46-year-old female without a history of exposure to carcinogens who presented with abdominal pain for two months. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.20344/amp.8593DOI Listing
October 2017
9 Reads

Imaging features of rare mesenychmal liver tumours: beyond haemangiomas.

Br J Radiol 2017 Nov 2;90(1079):20170373. Epub 2017 Aug 2.

1 Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Tumours arising from mesenchymal tissue components such as vascular, fibrous and adipose tissue can manifest in the liver. Although histopathology is often necessary for definitive diagnosis, many of these lesions exhibit characteristic imaging features. The radiologist plays an important role in suggesting the diagnosis, which can direct appropriate immunohistochemical staining at histology. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1259/bjr.20170373DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963373PMC
November 2017
21 Reads

Liver transplantation using the otherwise-discarded partial liver resection graft with hepatic benign tumor: Analysis of a preliminary experience on 15 consecutive cases.

Medicine (Baltimore) 2017 Jul;96(29):e7295

aLiver Transplantation Center bDepartment of Anesthesiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province cDepartment of General Surgery, Beijing Friendship Hospital, Capital Medical University dInstitute of Liver Transplantation, the General Hospital of Armed Forced Police, Beijing eDepartment of Surgical Oncology, The Eighty-First Hospital of People's Liberation Army, Nanjing, Jiangsu Province, P.R. China.

Rationale: The shortage of available donor organs limits the development of liver transplantation. This case-serial study presents a novel way to expand the donor pool by using the other-wise discarded partial liver resection graft with hepatic benign tumor.

Patient Concerns: From 2012 to 2016, 15 patients with hepatic lesions were admitted to our hospital. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000007295DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521882PMC
July 2017
23 Reads

Case report of a modified Meso-Rex bypass as a treatment technique for late-onset portal vein cavernous transformation with portal hypertension after adult deceased-donor liver transplantation.

Medicine (Baltimore) 2017 Jun;96(25):e7208

Department of Hepatopancreatobiliary Surgery, Medical Center, Tsinghua University, Beijing Tsinghua Changgung Hospital, Beijing, China.

Rationale: Portal vein thrombosis is a complication after liver transplantation and cavernous transformation of the portal vein (CTPV) is a result of portal vein thrombosis, with symptoms of portal hypertension revealed by an enhanced CT scan. Meso-Rex bypass is an artificial shunt connecting the left portal vein to the superior mesenteric vein and is mainly used for idiopathic cavernomas. This technique is also used for post-transplant portal vein thrombosis in pediatric patients thereby bypassing obstructed sites of the extrahepatic portal vein. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00005792-201706230-0003
Publisher Site
http://dx.doi.org/10.1097/MD.0000000000007208DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484218PMC
June 2017
21 Reads

Giant Caudate Lobe Hemangioma.

J Gastrointest Surg 2017 Nov 21;21(11):1957-1958. Epub 2017 Jun 21.

Department of Surgery, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, 19104, PA, USA.

Liver hemangiomas are the most common benign liver mass and typically asymptomatic and incidentally found. Giant liver hemangiomas are defined as having an overall diameter of >5 cm and more likely to be symptomatic. We present a case of a dominant caudate lobe hemangioma presented with weight loss and abdominal pain. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11605-017-3473-3DOI Listing
November 2017
3 Reads

[Giant hepatic hemangioma detected using CT scan].

Pan Afr Med J 2016;25:241. Epub 2016 Dec 20.

Service de Radiologie du CHU Hassan II, Fès, Maroc.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11604/pamj.2016.25.241.10363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337262PMC
April 2018
8 Reads

A Novel CCM1/KRIT1 Heterozygous Nonsense Mutation (c.1864C>T) Associated with Familial Cerebral Cavernous Malformation: a Genetic Insight from an 8-Year Continuous Observational Study.

J Mol Neurosci 2017 Apr 2;61(4):511-523. Epub 2017 Mar 2.

Department of Neurosurgery, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, No. 6 Tiantan Xili, Dongcheng District, Beijing, 100050, China.

Cerebral cavernous malformation (CCM) is a congenital vascular abnormality that predominantly affects the central nervous system, but that sometimes encroaches other vital tissues, including the retina, skin, and even liver. The familial form of CCM (FCCM) is considered to be an autosomal dominant disease with incomplete penetrance and variable expression, which is often attributed to mutations in three genes: CCM1, CCM2, and CCM3. We screened a Chinese family diagnosed with FCCM by using Sanger sequencing. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12031-017-0893-1DOI Listing
April 2017
12 Reads

Characteristics and operative treatment of extremely giant liver hemangioma >20 cm.

Surgery 2017 06 23;161(6):1514-1524. Epub 2017 Jan 23.

Department of Hepatobiliary Surgery, China-Japan Friendship Hospital, Beijing, China.

Background: Giant liver hemangioma >20 cm may cause severe complications; therefore, operative treatment can be highly difficult and risky. No studies have been performed to determine the characteristics of this subgroup.

Methods: A retrospective study was performed on 141 patients who underwent operative treatment for liver hemangioma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.surg.2016.12.015DOI Listing
June 2017
36 Reads

Cardiac Cavernous Hemangioma Coexisting With Pulmonary Cavernous Hemangiomas and Giant Hepatic Hemangioma.

Ann Thorac Surg 2017 Feb;103(2):e149-e152

Department of Cardiothoracic Surgery, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.

We describe a case of cardiac cavernous hemangioma with coexisting pulmonary cavernous hemangiomas and hepatic hemangioma. A 35-year-old woman who had previously received a living donor liver transplant to cure giant hepatic hemangioma was seen because of chest pain. A cardiac neoplasm and multiple pulmonary nodules were detected. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2016.07.024DOI Listing
February 2017
14 Reads

Diagnostic value of diffusion weighted MRI and ADC in differential diagnosis of cavernous hemangioma of the liver.

Afr Health Sci 2016 Mar;16(1):227-33

Bulent Ecevit University, School of Medicine, Department of Radiology, Zonguldak, Turkey.

Aims: To investigate the use of diffusion weighted magnetic resonance imaging (DWI) and the apparent diffusion coefficient (ADC) values in the diagnosis of hemangioma.

Materials And Methods: The study population consisted of 72 patients with liver masses larger than 1 cm (72 focal lesions). DWI examination with a b value of 600 s/mm2 was carried out for all patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4314/ahs.v16i1.30DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915395PMC
March 2016
20 Reads

Transarterial Chemoembolization of Giant Liver Haemangioma: A Multi-center Study with 836 Cases.

Cell Biochem Biophys 2015 Nov;73(2):469-472

Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan, 250033, Shandong, China.

The purpose of the study is to evaluate the effectiveness and safety of transarterial chemoembolization (TACE) with pingyangmycin-lipiodol emulsion for the treatment of symptomatic giant hepatic haemangioma. Four hospitals (The Second Hospital of Shandong University, Qilu Hospital of Shandong University, Shandong Provincial Hospital and Jinan Municipal Hospital) participated in this study during 2002-2012. A total of 836 patients with symptomatic giant haemangioma were treated with pingyangmycin-lipiodol emulsion via selective TACE. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12013-015-0680-yDOI Listing
November 2015
26 Reads

Myxoid hepatocellular neoplasms: imaging appearance of a unique mucinous tumor variant.

Abdom Radiol (NY) 2016 11;41(11):2115-2122

Division of Abdominal Imaging, Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Purpose: To describe the imaging appearance of myxoid hepatocellular neoplasms (MHNs), including adenomas and carcinomas, a recently described pathologically unique tumor variant.

Materials And Methods: Single-institution review of pathologically proven MHNs revealed 4 patients with imaging prior to resection. All available cross-sectional imaging was then retrospectively reviewed in consensus using specified descriptive characteristics previously published for hepatocellular adenoma subtypes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-016-0812-xDOI Listing
November 2016
1 Read

Treatment of atypically-localized cavernous hemangioma in abdomen with atypical pain.

Int J Surg Case Rep 2016 7;25:24-7. Epub 2016 Jun 7.

Department of Pathology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.

Introduction: Hemangiomas are the most common benign lesions of the liver. They usually remain asymptomatic and it is sufficient to follow up with intermittent imaging methods. The case presented herein featured with localization and atypical symptoms. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijscr.2016.05.058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913180PMC
August 2016
8 Reads

Pancreatic Islet Cells Mimicking Hepatic Metastases.

Am J Gastroenterol 2016 Jun;111(6):765

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2016.209DOI Listing
June 2016
16 Reads

 Giant cavernous hemangiomata of the liver: Watchful waiting, resection or transplantation?

Ann Hepatol 2016 Jul-Aug;15(4):586-7

Department of Transplantation. Mayo Clinic Florida, USA.

View Article

Download full-text PDF

Source
February 2017
7 Reads

Pendulous hepatic hemangioma.

Surgery 2017 06 9;161(6):1735-1736. Epub 2016 Apr 9.

General and Digestive Surgery Service, Elda General and University Hospital, Alicante, Spain; Nurse Department, Faculty of Health Sciences, University of Alicante, Alicante, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.surg.2016.02.036DOI Listing
June 2017
17 Reads

Stapler hepatectomy in giant cavernous hemangioma of liver.

Trop Gastroenterol 2016 Apr-Jun;37(2):142-3

View Article

Download full-text PDF

Source
October 2018

Pedunculated Hepatic Hemangioma Masquerading as a Peritoneal Tumor. A Case Report.

Pol J Radiol 2016 14;81:51-3. Epub 2016 Feb 14.

Department of Interventional Radiology, Polyclinique Les Fleurs, Ollioules, France.

Background: Although being classically located inside the liver parenchyma, hemangiomas may occasionally develop outside the extra-hepatic capsule, thus appearing as a pedunculated mass.

Case Report: We report the case of a 66-year-old anal cancer female patient presenting with an asymptomatic sub-hepatic mass. Incidental diagnosis of a pedunculated hepatic hemangioma was strongly suggested by the typical imaging features on computed tomography (CT) and magnetic resonance (MR) examinations, and was confirmed by histopathological examination. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12659/PJR.895327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763809PMC
March 2016
61 Reads

Same day arterial embolisation followed by hepatic resection for treatment of giant haemangioma.

BMJ Case Rep 2016 Feb 25;2016. Epub 2016 Feb 25.

HPB, Nottingham University Hospitals, Nottingham, Nottinghamshire, UK.

Cavernous haemangiomas are the most common tumour of the liver; they are benign in nature and have an incidence of up to 7.3% at autopsy. Occasionally, they may cause symptoms necessitating intervention. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2015-213259DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769450PMC
February 2016
3 Reads

Intraductal Sonography in Patients With Portal Cavernoma Cholangiopathy.

J Ultrasound Med 2016 Mar 22;35(3):651-9. Epub 2016 Feb 22.

Departments of Hepatology (V.B., S.M.S.) and Radiology (A.M.), Institute of Liver and Biliary Sciences, New Delhi, India.

Intraductal sonography generates high-resolution images of the entire length of the biliary tree and peribiliary tissues, including 3-dimensional dual- and muti-plane reconstructions to depict complex anatomy. Portal cavernoma cholangiopathy (previously called portal biliopathy) can have multiple etiologies of obstructive cholestasis in the same patient, which can be difficult to define even with advanced imaging techniques.We describe 2 difficult cases of portal cavernoma cholangiopathy in which intraductal sonography helped in clinical management decisions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7863/ultra.15.05013DOI Listing
March 2016
9 Reads
1.532 Impact Factor

Coexistence of splenic hemangioma and vascular malformation of the vertebrae.

BMC Res Notes 2016 Feb 9;9:76. Epub 2016 Feb 9.

Hematology and Oncology Research Center, Vali Asr Hospital, Tehran University of Medical Science, Tehran, Iran.

Background: Cavernous hemangioma is an encapsulated mass of dilated, endothelial lined vascular channels filled with slowly flowing blood. Cavernous hemangioma of the spleen is a rare condition with less than 100 reports so far. Hemangioma of the vertebral is a benign vascular legion around one or two vertebrae. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13104-016-1860-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748470PMC
February 2016
16 Reads

Exome capture sequencing identifies a novel CCM1 mutation in a Chinese family with multiple cerebral cavernous malformations.

Int J Neurosci 2016 Dec 7;126(12):1071-6. Epub 2015 Dec 7.

a 1 Department of Neurology , The First Affiliated Hospital of Zhengzhou University, Zhengzhou University , Zhengzhou , China.

Purpose: Cerebral cavernous malformations (CCMs) are vascular anomalies predominantly in the central nervous system but may include lesions in other tissues, such as the retina, skin and liver. The main clinical manifestations include seizures, hemorrhage, recurrent headaches and focal neurological deficits. Previous studies of familial CCMs (FCCMs) have mainly reported in Hispanic and Caucasian cases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00207454.2015.1118628DOI Listing
December 2016
41 Reads

Giant adrenal hemangioma: Unusual cause of huge abdominal mass.

Can Urol Assoc J 2015 Nov-Dec;9(11-12):E834-6. Epub 2015 Nov 4.

Department of Digestive Surgery II, Mohammed V Military Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.

Adrenal hemangioma is an extremely rare benign and non-functioning neoplasm of the adrenal gland. We report a case of a 71-year-old woman admitted for intermittent abdominal pain and abdominal distension associated with vomiting and chronic constipation for 5 years. Physical examination revealed a large abdominal mass. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.2967DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639440PMC
November 2015
24 Reads
3 Citations
1.920 Impact Factor

[Treatment of non-cirrhotic, non-tumoural portal vein thrombosis].

Gastroenterol Hepatol 2016 Jun-Jul;39(6):403-10. Epub 2015 Nov 4.

CTO, Department of Medicine, Icahn School of Medicine at Mount Sinai, Nueva York, Estados Unidos. Electronic address:

Thrombosis of the splenoportal axis not associated with liver cirrhosis or neoplasms is a rare disease whose prevalence ranges from 0.7 to 3.7 per 100,000 inhabitants. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S02105705150023
Publisher Site
http://dx.doi.org/10.1016/j.gastrohep.2015.09.007DOI Listing
November 2017
28 Reads

Education and Imaging: Hepatobiliary and Pancreatic: Extrahepatic cavernous hemangioma presenting as a palpable abdominal mass.

J Gastroenterol Hepatol 2015 Nov;30(11):1565

Wheaton Franciscan Healthcare, Medicine, Milwaukee, Wisconsin, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.12985DOI Listing
November 2015
3 Reads

[Natural history of portal cavernoma without liver disease. A single centre retrospective study of 32 cases].

Rev Med Interne 2016 Jun 19;37(6):394-8. Epub 2015 Sep 19.

Service de médecine interne, hôpital Gabriel-Montpied, CHU de Clermont-Ferrand, 58, rue Montalembert, 63003 Clermont-Ferrand cedex 1, France; Faculté de médecine, université d'Auvergne, 63001 Clermont-Ferrand, France; Inserm, U1071, M2iSH, 63001 Clermont-Ferrand, France.

Purpose: Portal cavernoma follows a chronic occlusion of the portal vein. The long-term consequences of portal cavernoma are not well known. The objective of this study was to report the aetiology of the portal cavernoma and its natural course after excluding liver diseases causes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.revmed.2015.07.017DOI Listing
June 2016
3 Reads

Hepatic angiomyolipoma with special attention to radiologic imaging.

Surg Case Rep 2015 24;1(1):38. Epub 2015 Apr 24.

Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto City, Kumamoto 860-8556 Japan.

Background: Angiomyolipoma is a unique mesenchymal neoplasm composed of blood vessels as well as smooth muscle and adipose cells. The liver is a less common site of origin, and hepatic angiomyolipoma is often an incidental finding on diagnostic imaging or is identified on evaluation of nonspecific symptoms.

Case Presentation: We experienced four patients who were diagnosed histologically with hepatic angiomyolipoma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40792-015-0038-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560139PMC
March 2016
4 Reads

Transcatheter Arterial Embolization Alone for Giant Hepatic Hemangioma.

PLoS One 2015 19;10(8):e0135158. Epub 2015 Aug 19.

Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Giant hepatic hemangioma is a benign liver condition that may be treated using surgery. We studied the digital subtraction angiographic (DSA) characteristics of giant hepatic hemangioma, and the effectiveness of transcatheter arterial embolization (TAE) alone for its treatment. This was a retrospective study of 27 patients diagnosed with giant hepatic hemangioma and treated with TAE alone (using lipiodol mixed with pingyangmycin) at the Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University, between January 2010 and March 2013. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0135158PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545419PMC
May 2016
30 Reads

[Hepatic angiosarcoma and liver transplantation: case report and literature review].

Cir Cir 2015 Nov-Dec;83(6):510-5. Epub 2015 Jul 3.

Departamento de Cirugía General, Unidad Médica de Alta Especialidad, Hospital de Especialidades del Centro Médico Nacional de Occidente Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, México.

Background: Hepatic angiosarcoma is a rare vascular malignancy that accounts for 2% of all hepatic primary tumours. The diagnosis is difficult, especially if the patient does not have history of exposure to carcinogens, which are considered as risk factors. The diagnosis is made by histopathology, but in a considerable percentage it can only be accomplished by autopsy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.circir.2015.05.027DOI Listing
September 2016
21 Reads

A giant cavernous hemangioma of the liver extending into the pelvis.

Int J Surg Case Rep 2015 19;13:51-4. Epub 2015 Jun 19.

Department of Surgery, Division of Surgical Oncology, Baylor College of Medicine, Houston, TX, USA; Houston VA HSR&D Center for Innovations in Quality, Effectiveness and Safety (IQUEST), Michael E. DeBakey VA Medical Center, Houston, TX, USA. Electronic address:

Introduction: Giant cavernous hemangiomas are the most common tumors of the liver, ocurring in up to 20% of the general population. Given their benign course, asymptomatic nature and slow growth rate, treatment is rarely indicated. The case presented herein is unique as it describes an uncommon presentation of this common tumor and the circumstances in which surgical treatment is beneficial. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijscr.2015.06.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529641PMC
August 2015
8 Reads

Hepatic Sclerosed Hemangioma: a case report and review of the literature.

BMC Surg 2015 Apr 17;15:45. Epub 2015 Apr 17.

Department of Surgery, JA Hiroshima General Hospital, 1-3-3, Jigozen, 738-8503,, Hatsukaichi, Japan.

Background: Although cavernous hemangioma is one of the most frequently encountered benign hepatic neoplasms, hepatic sclerosed hemangioma is very rare. We report a case of hepatic sclerosed hemangioma that was difficult to distinguish from an intrahepatic cholangiocarcinoma by imaging studies.

Case Presentation: A 76-year-old male patient with right hypochondralgia was referred to our hospital. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12893-015-0029-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428228PMC
April 2015
5 Reads

Hepatic hemangioma masquerading as a tumor originating from the stomach.

Oncol Lett 2015 Mar 12;9(3):1406-1408. Epub 2015 Jan 12.

Department of Gastrointestinal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, P.R. China.

Hemangioma is the most common benign hepatic neoplasm. The majority of cases are asymptomatic and can be confirmed by imaging examinations, including enhanced computed tomography and magnetic resonance imaging. Exophytic growth is not common and pedunculated cases are extremely rare. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2015.2863DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315127PMC
March 2015
4 Reads

Adult hepatic cavernous hemangioma with highly elevated α-fetoprotein: A case report and review of the literature.

Oncol Lett 2015 Feb 4;9(2):637-640. Epub 2014 Dec 4.

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510080, P.R. China.

A 47-year-old male presented with a six-month history of fatigue and a four-month history of alanine and aspartate aminopherase elevation. Laboratory examination revealed that the serum α-fetoprotein (AFP) level was 371.51 μg/l (normal range, 0-20 μg/l), and a computed tomography scan revealed a hypodense lesion in the left hepatic lobe. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2014.2769DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301549PMC
February 2015
9 Reads

Sclerosing cholangitis secondary to bleomycin-iodinated embolization for liver hemangioma.

World J Gastroenterol 2014 Dec;20(46):17680-5

Shuo Jin, Xiao-Ju Shi, Xiao-Dong Sun, Guang-Yi Wang, Department of Hepatobiliary and Pancreatic Surgery, the First Norman Bethune Hospital Affiliated to Jilin University, Changchun 130021, Jilin Province, China.

Sclerosing cholangitis (SC) is a rarely reported morbidity secondary to transcatheter arterial chemoembolization (TACE) with bleomycin-iodinated oil (BIO) for liver cavernous hemangioma (LCH). This report retrospectively evaluated the diagnostic and therapeutic course of a patient with LDH who presented obstructive jaundice 6 years after TACE with BIO. Preoperative imaging identified a suspected malignant biliary stricture located at the convergence of the left and right hepatic ducts. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v20.i46.17680DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265633PMC
December 2014
52 Reads

Primary hepatic vascular tumours. A clinicopathologic study of 10 cases.

Acta Gastroenterol Belg 2014 Sep;77(3):347-52

Background: Primary hepatic vascular neoplasms constitute a heterogeneous group of neoplasms with characteristic histology and variable tumour biology.

Aim: To provide an updated overview on clinicopathological features, treatment and outcome of primary hepatic vascular tumours.

Patients And Methods: In our retrospective study, we reviewed 10 cases of primary hepatic vascular tumours that were diagnosed at the pathology department of Mongi Slim hospital over a thirteen-year period (2000-2012). Read More

View Article

Download full-text PDF

Source
September 2014
6 Reads

Primary mesenchymal liver tumors: radiological spectrum, differential diagnosis, and pathologic correlation.

Abdom Imaging 2015 Jun;40(5):1316-30

Department of Radiology, Faculty of Medicine, University of Ege, İzmir, Turkey,

With the exception of hemangioma, benign or malignant primary mesenchymal tumors of the liver are seldom encountered. The aim of this review was to discuss the clinical, histopathological, and imaging features of liver hemangiomas (cavernous, capillary, and sclerosed types), liver lipoma, angiomyolipoma, mesenchymal hamartoma, neurofibroma, infantile hemangioendothelioma, epithelioid hemangioendothelioma, myofibroblastoma, angiosarcoma, malignant fibrous histiocytoma, undifferentiated embryonal sarcoma, and nested stromal tumor. In most of these rare liver tumors, radiological findings obtained by cross-sectional imaging may reflect the characteristic pathologic features required for differential diagnosis; however, definitive diagnosis should be confirmed using histopathological examination. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-014-0268-9DOI Listing
June 2015
15 Reads

Primary hepatic angiosarcoma: multi-institutional comprehensive cancer centre review of multiphasic CT and MR imaging in 35 patients.

Eur Radiol 2015 Feb 4;25(2):315-22. Epub 2014 Oct 4.

Department of Radiology, University of Wisconsin School of Medicine & Public Health, E3/311 Clinical Science Center, 600 Highland Ave, Madison, WI, 53792-3252, USA,

Objective: To assess the imaging features of primary hepatic angiosarcoma on multiphasic CT and MR.

Methods: Multi-institutional review identified 35 adults (mean age, 57.1 years; 22M/13F) with pathologically proven hepatic angiosarcoma and pretreatment multiphasic CT (n = 33) and/or MR (n = 7). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-014-3442-0DOI Listing
February 2015
15 Reads

Diffuse Hepatic Hemangiomatosis in the Adult without Extra-hepatic Involvement: An Extremely Rare Occurrence.

J Clin Imaging Sci 2014 30;4:43. Epub 2014 Aug 30.

Department of Radiology, Hospital Garcia de Orta, Almada, Portugal.

We present a case of a pathologically proven multinodular diffuse hepatic hemangiomatosis (DHH) with no extra-hepatic involvement in a 68-year-old male. Cavernous hemangioma is the most common hepatic tumor. However, DHH, which is characterized by extensive replacement of liver parenchyma with hemangiomatous lesions, has been rarely reported in adults. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/2156-7514.139733DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168547PMC
September 2014
6 Reads
1 Citation

Diagnosis and management of solid benign liver lesions.

Nat Rev Gastroenterol Hepatol 2014 Dec 2;11(12):737-49. Epub 2014 Sep 2.

Department of Radiology, Beaujon Hospital, University Paris-Diderot, 100 Boulevard du General Leclerc, 92110 Clichy, France.

More and more asymptomatic benign liver tumours are discovered incidentally and can be divided into regenerative lesions and true neoplastic lesions. The most common regenerative lesions include hemangioma, focal nodular hyperplasia and inflammatory pseudotumours of the liver. Neoplastic lesions include hepatocellular adenomas and angiomyolipomas. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2014.151DOI Listing
December 2014
12 Reads

Microwave ablation of giant hepatic cavernous hemangiomas.

Cardiovasc Intervent Radiol 2014 Oct 15;37(5):1299-305. Epub 2014 Jul 15.

Department of Radiology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, E3/366, Madison, WI, 53792-3252, USA,

Purpose: This study was designed to explore the safety and efficacy of percutaneous microwave (MW) ablation as an alternative treatment for symptomatic giant hepatic hemangiomas.

Methods: Patients (n = 7; 6 females, 1 male; mean age = 44 years) with symptomatic, giant hemangiomas (n = 8) were treated with ultrasound-guided percutaneous MW ablation and followed for a mean of 18 months. Patient pain was recorded both before and after the procedure according to the 10-point visual analog scale. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00270-014-0934-xDOI Listing
October 2014
46 Reads